Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

West Pharmaceutical Services Inc

WST ✓ COMPLIANT ☆ Track — members

NYSE · Healthcare · Medical Equipment, Supplies & Distribution ·

USA Large Cap Analyst: BUY

Last Close

$349.42

▲ +0.94%

Market Cap $24.59B · Vol 146.02K

Key Metrics

P/E Ratio

44.67

FWD: 36.52

Market Cap

$24.59B

Large Cap

Div Yield

0.25%

Quarterly dividend

EPS Growth

+22.82%

YoY

RSI (14)

72.34

Momentum

Beta

1.13

vs Market

52W High

$386.00

9.48% below

52W Low

$223.84

56.10% above

Volume

146.02K

Avg 215.34K

P/B

6.24

Price-to-book

ROE

18.09%

Return on equity

Free Float

99.34%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, West Pharmaceutical Services Inc (WST) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does WST pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-1.31%

-2.30%

+16.40%

+39.49%

YTD

+27.00%

+41.93%

-13.11%

-19.54%

Financials & Valuation

TTM · Annual

Total Revenue	$3.07B
Net Income	$479.30M
Revenue Growth (YoY)	+13.80%
Gross Margin	35.91%
Operating Margin	20.81%
Net Profit Margin	16.06%
ROE	18.09%
ROA · ROIC	15.19% · 15.76%

P/E Ratio	44.67
Forward P/E (FY1)	36.52
PEG Ratio	25.62
P/S	6.51
P/B	6.24
P/FCF	42.66
EPS Growth	+22.82%
Outstanding Shares	70.38M

Technical Indicators

50-Day SMA	$345.09
200-Day SMA	$288.48
RSI (14)	72.34
Beta	1.13
52-Week High	$386.00
52-Week Low	$223.84

Volume Today	146.02K
Avg Daily Volume (30D)	215.34K
Relative Volume	0.68x
Volatility (10D)	16.78
Volatility (30D)	28.91
Free Float	99.34%

Analyst Consensus

BUY

Current Price $349.42

Mean Target $397.09

52W Low$223.84 52W High$386.00

Current

Target

$223.84 $386.00

Current Analyst target

+13.64% upside potential · 18 analysts

Identifiers

ExchangeNYSE

FIGIBBG001S5XK22

ISINUS9553061055

CountryUnited States of America

Sub-IndustryMedical Equipment, Supplies & Distribution (NEC)

Earnings DateOct 21, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

ABT Abbott Laboratories -0.02% MDT Medtronic PLC +0.76% COR Cencora Inc +1.23% 7741.T Hoya Corp +0.32% BDX Becton Dickinson and Co +0.79%

Company Profile

West Pharmaceutical Services Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its segments include Proprietary Products and West Vantage. Its Proprietary Products segment offers proprietary packaging, containment solutions and drug delivery systems, along with analytical lab services and other integrated services and solutions, primarily for biologic, generic and pharmaceutical drug customers. Its West Vantage segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, as well as combination product assembly and packaging, primarily for pharmaceutical, diagnostic, and medical device customers. It also maintains collaborations to share technologies and market products with affiliates in Japan and Mexico. Its customers include generic, pharmaceutical, diagnostic, and medical device companies.